Lebanese medicine crisis extends to cancer drugs

A Lebanese cancer patient suffered severe complications after a dose of chemotherapy, raising questions about the quality of cancer medications available in Lebanon. Authorities have taken action to investigate the credibility and efficacy of six types of these drugs, amid concerns about the entry of smuggled or non-compliant medicines. The case has been referred to the public prosecutor. Experts confirmed that the quality of medications depends on manufacturing sources and registration, and that contamination or poor storage can increase risks. They called for stricter oversight and warned against purchasing medicines from unlicensed sources.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل